Macquarie Group LTD Neuronetics, Inc. Transaction History
Macquarie Group LTD
- $90.3 Billion
- Q3 2024
Shares
2 transactions
Others Institutions Holding STIM
# of Institutions
48Shares Held
13MCall Options Held
30.1KPut Options Held
0-
Kent Lake Pr LLC Anasco, PR2.08MShares$6.21 Million0.63% of portfolio
-
Kent Lake Capital LLC Mill Valley, CA1.74MShares$5.2 Million1.44% of portfolio
-
Cannell Capital LLC Alta, WY1.31MShares$3.93 Million0.23% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.3MShares$3.89 Million0.0% of portfolio
-
Masters Capital Management LLC Atlanta, GA1.2MShares$3.59 Million0.05% of portfolio
About Neuronetics, Inc.
- Ticker STIM
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 27,022,800
- Market Cap $80.8M
- Description
- Neuronetics, Inc., a commercial stage medical technology company, designs, develops, and markets products for patients with neurohealth disorders in the United States and internationally. The company offers NeuroStar Advanced Therapy System, a non-invasive and non-systemic office-based treatment to treat adult patients with major depressive diso...